Search results
Results from the WOW.Com Content Network
A national coverage determination (NCD) [1] is a United States nationwide determination of whether Medicare will pay for an item or service. [2] It is a form of utilization management and forms a medical guideline on treatment.
This law, which is administered by the Department of Labor and Health and Human Services, states that group health plans, insurance companies, and health maintenance organizations (HMOs) must provide coverage for reconstructive surgery after mastectomy for breast cancer and prohibited "drive-through" mastectomies, where breast cancer patient's ...
An influential task force just updated guidance on breast cancer screenings for at-risk women. They recommended every-other-year mammograms starting at age 40, a decade earlier than previous guidance.
Breast ultrasounds may be used with or without a mammogram. Breast ultrasound is the use of medical ultrasonography to perform imaging of the breast. It can be used as either a diagnostic or a screening procedure. [38] It may be used either with or without a mammogram. [39]
"The most common sign of breast cancer is a lump, deep in the breast.It often feels hard, like a lemon seed, and usually immovable. It can be any shape or size," said the site. You might also see ...
Medicare Part B covers outpatient blood tests ordered by a physician with a medically necessary diagnosis based on Medicare coverage guidelines. Examples would be screening blood tests to diagnose ...
Automated whole-breast ultrasound (AWBU) is a technique that produces volumetric images of the breast and is largely independent of operator skill. It utilizes high-frequency ultrasound to help perform a diagnostic evaluation of the lactiferous ducts ( duct sonography ) [ 5 ] and make dilated ducts and intraductal masses visible.
MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body. [1] It gives a binary result, high-risk or low-risk classification , and helps physicians determine whether or not a patient will benefit from chemotherapy .